G-IVF Trademark

Trademark Overview

On Friday, October 7, 2022, a trademark application was filed for G-IVF with the United States Patent and Trademark Office. The USPTO has given the G-IVF trademark a serial number of 79355223. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Vitrolife Sweden AB. The G-IVF trademark is filed in the Pharmaceutical Products category with the following description:

Fertilization media to support oocyte and sperm function and provide antioxidant protection during fertilization to improve embryo viability for medical or clinical use
g-ivf

General Information

Serial Number79355223
Word MarkG-IVF
Filing DateFriday, October 7, 2022
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7227060
Registration DateTuesday, November 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements

Goods and ServicesFertilization media to support oocyte and sperm function and provide antioxidant protection during fertilization to improve embryo viability for medical or clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, November 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVitrolife Sweden AB
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressVastra Frolunda
SE
Party NameVitrolife Sweden AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressVastra Frolunda
SE
Party NameVitrolife Sweden AB
Party Type12 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressVastra Frolunda
SE
Party NameVitrolife Sweden AB
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameVitrolife Sweden AB
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressSE

Trademark Events

Event DateEvent Description
Tuesday, March 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 1, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, November 11, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 12, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 23, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, August 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 8, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, August 8, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 17, 2023REFUSAL PROCESSED BY IB
Wednesday, April 26, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 26, 2023REFUSAL PROCESSED BY MPU
Wednesday, March 8, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 7, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, March 2, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 1, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, November 22, 2022APPLICATION FILING RECEIPT MAILED
Friday, November 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

fertilization improve during embryo viability clinical medical protection antioxidant support